Loading…

Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the Literature

To assess the efficacy of XEN-implant surgery in patients with glaucoma, and to perform a meta-analysis of previously published results and compare these to our data. Prospective case-control study, in which all eyes that underwent XEN-implant surgery were included from 2015 onwards. Sub-analyses we...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2021-03, Vol.10 (5), p.1118
Main Authors: Poelman, Huub J, Pals, Jan, Rostamzad, Parinaz, Bramer, Wichor M, Wolfs, Roger C W, Ramdas, Wishal D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c409t-fd44212d550894bfce011968c11d7b59bba87f8eca793eb5bf20724cef7f6f903
cites cdi_FETCH-LOGICAL-c409t-fd44212d550894bfce011968c11d7b59bba87f8eca793eb5bf20724cef7f6f903
container_end_page
container_issue 5
container_start_page 1118
container_title Journal of clinical medicine
container_volume 10
creator Poelman, Huub J
Pals, Jan
Rostamzad, Parinaz
Bramer, Wichor M
Wolfs, Roger C W
Ramdas, Wishal D
description To assess the efficacy of XEN-implant surgery in patients with glaucoma, and to perform a meta-analysis of previously published results and compare these to our data. Prospective case-control study, in which all eyes that underwent XEN-implant surgery were included from 2015 onwards. Sub-analyses were performed for eyes that underwent XEN-implant as standalone procedure and as cataract-combined procedure. To compare our results, a systematic review was performed using the Embase, PubMed, Web of Science, and Cochrane database. Meta-analyses were performed by combining data (intraocular pressure (IOP), IOP-lowering medication, and complications) from the retrieved studies. A total of 221 eyes underwent XEN-implant surgery (124 standalone and 97 cataract-combined). The mean ± standard deviation IOP declined from 18.8 ± 6.5 to 13.5 ± 4.3 mmHg at the last follow-up ( < 0.001; 28.9%). Postoperative, no significant differences in IOP or IOP-lowering medication were found between patients with and without combined procedure. Secondary surgeries were performed in 20.8% of eyes, most of them (63.0%) within six months. A meta-analysis of 19 studies retrieved from the systematic review showed a two-years postoperative pooled mean (weighted mean difference) of 14.5 (7.3) mmHg and 1.0 (1.6) for IOP and IOP-lowering medications, respectively (compared to 13.5 (5.3) mmHg and 3.2 (2.4) in the current study). XEN-implant surgery was effective and safe in lowering IOP and the number of IOP-lowering medications. There were no differences between standalone and combined procedures.
doi_str_mv 10.3390/jcm10051118
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7962186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2508570695</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-fd44212d550894bfce011968c11d7b59bba87f8eca793eb5bf20724cef7f6f903</originalsourceid><addsrcrecordid>eNpdke9LAyEchyWKFmuveh9Cb4K40tM79U0QY63BVm8Keieep81xP5beBfvvM7bFyjcKPn54vn4AuMDolhCB7la6xghlGGN-BM5SxFiCCCfHB-cBGIWwQnFxTlPMTsGAEI4QxukZWEysdVrpDWwt7JYGvk-ek1m9rlTTQdfAaaV63dYKqqaECi5Mp5KHRlWb4ML-ydx1xquu9-YcnFhVBTPa7UPw9jh5HT8l85fpbPwwTzRFoktsSaNIWmYZ4oIWVpsoI3KuMS5ZkYmiUJxZbrRigpgiK2wcJqXaWGZzKxAZgvtt7rovalNq03ReVXLtXa38RrbKyb83jVvKj_ZLMpGnmOcx4HoX4NvP3oRO1i5oU8WxTdsHmUazjKFcZBG9-oeu2t7HL4hUTjGiGWVppG62lPZtCN7YXxmM5E9T8qCpSF8e-v-y-17INxmsjT0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2641045472</pqid></control><display><type>article</type><title>Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the Literature</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Poelman, Huub J ; Pals, Jan ; Rostamzad, Parinaz ; Bramer, Wichor M ; Wolfs, Roger C W ; Ramdas, Wishal D</creator><creatorcontrib>Poelman, Huub J ; Pals, Jan ; Rostamzad, Parinaz ; Bramer, Wichor M ; Wolfs, Roger C W ; Ramdas, Wishal D</creatorcontrib><description>To assess the efficacy of XEN-implant surgery in patients with glaucoma, and to perform a meta-analysis of previously published results and compare these to our data. Prospective case-control study, in which all eyes that underwent XEN-implant surgery were included from 2015 onwards. Sub-analyses were performed for eyes that underwent XEN-implant as standalone procedure and as cataract-combined procedure. To compare our results, a systematic review was performed using the Embase, PubMed, Web of Science, and Cochrane database. Meta-analyses were performed by combining data (intraocular pressure (IOP), IOP-lowering medication, and complications) from the retrieved studies. A total of 221 eyes underwent XEN-implant surgery (124 standalone and 97 cataract-combined). The mean ± standard deviation IOP declined from 18.8 ± 6.5 to 13.5 ± 4.3 mmHg at the last follow-up ( &lt; 0.001; 28.9%). Postoperative, no significant differences in IOP or IOP-lowering medication were found between patients with and without combined procedure. Secondary surgeries were performed in 20.8% of eyes, most of them (63.0%) within six months. A meta-analysis of 19 studies retrieved from the systematic review showed a two-years postoperative pooled mean (weighted mean difference) of 14.5 (7.3) mmHg and 1.0 (1.6) for IOP and IOP-lowering medications, respectively (compared to 13.5 (5.3) mmHg and 3.2 (2.4) in the current study). XEN-implant surgery was effective and safe in lowering IOP and the number of IOP-lowering medications. There were no differences between standalone and combined procedures.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm10051118</identifier><identifier>PMID: 33800112</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Cataracts ; Clinical medicine ; Eye surgery ; Glaucoma ; Meta-analysis ; Patients ; Surgical techniques ; Systematic review ; Transplants &amp; implants ; Variables</subject><ispartof>Journal of clinical medicine, 2021-03, Vol.10 (5), p.1118</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-fd44212d550894bfce011968c11d7b59bba87f8eca793eb5bf20724cef7f6f903</citedby><cites>FETCH-LOGICAL-c409t-fd44212d550894bfce011968c11d7b59bba87f8eca793eb5bf20724cef7f6f903</cites><orcidid>0000-0002-7056-5432 ; 0000-0001-8523-5471 ; 0000-0002-1780-5281</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2641045472/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2641045472?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33800112$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Poelman, Huub J</creatorcontrib><creatorcontrib>Pals, Jan</creatorcontrib><creatorcontrib>Rostamzad, Parinaz</creatorcontrib><creatorcontrib>Bramer, Wichor M</creatorcontrib><creatorcontrib>Wolfs, Roger C W</creatorcontrib><creatorcontrib>Ramdas, Wishal D</creatorcontrib><title>Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the Literature</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>To assess the efficacy of XEN-implant surgery in patients with glaucoma, and to perform a meta-analysis of previously published results and compare these to our data. Prospective case-control study, in which all eyes that underwent XEN-implant surgery were included from 2015 onwards. Sub-analyses were performed for eyes that underwent XEN-implant as standalone procedure and as cataract-combined procedure. To compare our results, a systematic review was performed using the Embase, PubMed, Web of Science, and Cochrane database. Meta-analyses were performed by combining data (intraocular pressure (IOP), IOP-lowering medication, and complications) from the retrieved studies. A total of 221 eyes underwent XEN-implant surgery (124 standalone and 97 cataract-combined). The mean ± standard deviation IOP declined from 18.8 ± 6.5 to 13.5 ± 4.3 mmHg at the last follow-up ( &lt; 0.001; 28.9%). Postoperative, no significant differences in IOP or IOP-lowering medication were found between patients with and without combined procedure. Secondary surgeries were performed in 20.8% of eyes, most of them (63.0%) within six months. A meta-analysis of 19 studies retrieved from the systematic review showed a two-years postoperative pooled mean (weighted mean difference) of 14.5 (7.3) mmHg and 1.0 (1.6) for IOP and IOP-lowering medications, respectively (compared to 13.5 (5.3) mmHg and 3.2 (2.4) in the current study). XEN-implant surgery was effective and safe in lowering IOP and the number of IOP-lowering medications. There were no differences between standalone and combined procedures.</description><subject>Cataracts</subject><subject>Clinical medicine</subject><subject>Eye surgery</subject><subject>Glaucoma</subject><subject>Meta-analysis</subject><subject>Patients</subject><subject>Surgical techniques</subject><subject>Systematic review</subject><subject>Transplants &amp; implants</subject><subject>Variables</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdke9LAyEchyWKFmuveh9Cb4K40tM79U0QY63BVm8Keieep81xP5beBfvvM7bFyjcKPn54vn4AuMDolhCB7la6xghlGGN-BM5SxFiCCCfHB-cBGIWwQnFxTlPMTsGAEI4QxukZWEysdVrpDWwt7JYGvk-ek1m9rlTTQdfAaaV63dYKqqaECi5Mp5KHRlWb4ML-ydx1xquu9-YcnFhVBTPa7UPw9jh5HT8l85fpbPwwTzRFoktsSaNIWmYZ4oIWVpsoI3KuMS5ZkYmiUJxZbrRigpgiK2wcJqXaWGZzKxAZgvtt7rovalNq03ReVXLtXa38RrbKyb83jVvKj_ZLMpGnmOcx4HoX4NvP3oRO1i5oU8WxTdsHmUazjKFcZBG9-oeu2t7HL4hUTjGiGWVppG62lPZtCN7YXxmM5E9T8qCpSF8e-v-y-17INxmsjT0</recordid><startdate>20210307</startdate><enddate>20210307</enddate><creator>Poelman, Huub J</creator><creator>Pals, Jan</creator><creator>Rostamzad, Parinaz</creator><creator>Bramer, Wichor M</creator><creator>Wolfs, Roger C W</creator><creator>Ramdas, Wishal D</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7056-5432</orcidid><orcidid>https://orcid.org/0000-0001-8523-5471</orcidid><orcidid>https://orcid.org/0000-0002-1780-5281</orcidid></search><sort><creationdate>20210307</creationdate><title>Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the Literature</title><author>Poelman, Huub J ; Pals, Jan ; Rostamzad, Parinaz ; Bramer, Wichor M ; Wolfs, Roger C W ; Ramdas, Wishal D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-fd44212d550894bfce011968c11d7b59bba87f8eca793eb5bf20724cef7f6f903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cataracts</topic><topic>Clinical medicine</topic><topic>Eye surgery</topic><topic>Glaucoma</topic><topic>Meta-analysis</topic><topic>Patients</topic><topic>Surgical techniques</topic><topic>Systematic review</topic><topic>Transplants &amp; implants</topic><topic>Variables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poelman, Huub J</creatorcontrib><creatorcontrib>Pals, Jan</creatorcontrib><creatorcontrib>Rostamzad, Parinaz</creatorcontrib><creatorcontrib>Bramer, Wichor M</creatorcontrib><creatorcontrib>Wolfs, Roger C W</creatorcontrib><creatorcontrib>Ramdas, Wishal D</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Hospital Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poelman, Huub J</au><au>Pals, Jan</au><au>Rostamzad, Parinaz</au><au>Bramer, Wichor M</au><au>Wolfs, Roger C W</au><au>Ramdas, Wishal D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the Literature</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2021-03-07</date><risdate>2021</risdate><volume>10</volume><issue>5</issue><spage>1118</spage><pages>1118-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>To assess the efficacy of XEN-implant surgery in patients with glaucoma, and to perform a meta-analysis of previously published results and compare these to our data. Prospective case-control study, in which all eyes that underwent XEN-implant surgery were included from 2015 onwards. Sub-analyses were performed for eyes that underwent XEN-implant as standalone procedure and as cataract-combined procedure. To compare our results, a systematic review was performed using the Embase, PubMed, Web of Science, and Cochrane database. Meta-analyses were performed by combining data (intraocular pressure (IOP), IOP-lowering medication, and complications) from the retrieved studies. A total of 221 eyes underwent XEN-implant surgery (124 standalone and 97 cataract-combined). The mean ± standard deviation IOP declined from 18.8 ± 6.5 to 13.5 ± 4.3 mmHg at the last follow-up ( &lt; 0.001; 28.9%). Postoperative, no significant differences in IOP or IOP-lowering medication were found between patients with and without combined procedure. Secondary surgeries were performed in 20.8% of eyes, most of them (63.0%) within six months. A meta-analysis of 19 studies retrieved from the systematic review showed a two-years postoperative pooled mean (weighted mean difference) of 14.5 (7.3) mmHg and 1.0 (1.6) for IOP and IOP-lowering medications, respectively (compared to 13.5 (5.3) mmHg and 3.2 (2.4) in the current study). XEN-implant surgery was effective and safe in lowering IOP and the number of IOP-lowering medications. There were no differences between standalone and combined procedures.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>33800112</pmid><doi>10.3390/jcm10051118</doi><orcidid>https://orcid.org/0000-0002-7056-5432</orcidid><orcidid>https://orcid.org/0000-0001-8523-5471</orcidid><orcidid>https://orcid.org/0000-0002-1780-5281</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2077-0383
ispartof Journal of clinical medicine, 2021-03, Vol.10 (5), p.1118
issn 2077-0383
2077-0383
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7962186
source Publicly Available Content Database; PubMed Central
subjects Cataracts
Clinical medicine
Eye surgery
Glaucoma
Meta-analysis
Patients
Surgical techniques
Systematic review
Transplants & implants
Variables
title Efficacy of the XEN-Implant in Glaucoma and a Meta-Analysis of the Literature
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-09T15%3A42%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20the%20XEN-Implant%20in%20Glaucoma%20and%20a%20Meta-Analysis%20of%20the%20Literature&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Poelman,%20Huub%20J&rft.date=2021-03-07&rft.volume=10&rft.issue=5&rft.spage=1118&rft.pages=1118-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm10051118&rft_dat=%3Cproquest_pubme%3E2508570695%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c409t-fd44212d550894bfce011968c11d7b59bba87f8eca793eb5bf20724cef7f6f903%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2641045472&rft_id=info:pmid/33800112&rfr_iscdi=true